Abstract: A medium conveyance device includes an openable and closable cover that covers a conveyance path for a medium, a sensor that includes a transmission unit which transmits a measured object and a reception unit which receives the measured object transmitted from the transmission unit, the sensor for detection of the medium being present on the conveyance path, and a processor that increases a transmission level of the transmission unit when a reception level for the measured object received by the reception unit is less than a threshold, and determines whether the cover is opened based on whether a rate of change of the reception level between before and after an increase in the transmission level is less than a threshold.

Abstract: It is intended to provide a novel agent for promoting the recovery from dysfunction after the onset of a central neurological disease or an agent for enhancing and/or promoting the effect of rehabilitation for functional recovery. Namely, an agent for promoting the recovery from dysfunction after the onset of a central neurological disease which contains, as the active ingredient, a compound capable of simultaneously and selectively enhancing neurotransmission by serotonin and neurotransmission by norepinephrine; and an agent for enhancing and/or promoting the effect of rehabilitation for functional recovery after the onset of a central neurological disease which contains, as the active ingredient, a compound capable of simultaneously and selectively enhancing neurotransmission by serotonin and neurotransmission by norepinephrine.

Abstract: This invention is to provide remedies for ischemic stroke which contain as an active ingredient a compound having mGluR1 antagonism, pharmaceutical compositions which are remedies for ischemic stroke at the acute stage, pharmaceutical compositions which contain as an active ingredient a compound having selective mGluR1 antagonism, and pharmaceutical compositions wherein the compound having selective mGluR1 antagonism is 6-amino-N-cyclohexyl-N,3 -dimethylthiazolo[3,2-a]benzoimidazole-2-carboxamide dihydrochloride.